Neupro can treat Parkinson's disease and Restless Legs Syndrome
Neupro can treat Parkinson's disease and Restless Legs Syndrome
UCB has announced the launch of Neupro in the United States for the treatment of Parkinson's disease and restless legs syndrome. The once-daily patch provides continuous delivery of the dopamine agonist rotigotine. The Food & Drug Administration approved the medication in April. Parkinson's affects about one million Americans, while up to 23 million Americans may be afflicted by Restless Leg Syndrome.
